MedLife S.A.

Report Publication Announcement • Feb 28, 2025

To: BUCHAREST STOCK EXCHANGE FINANCIAL SUPERVISORY AUTHORITY

ANNOUNCEMENT

Report Date: 28 February 2025 Name of the issuing company: MED LIFE S.A. ("MedLife" or "the Company") Registered Office: Bucharest, Calea Grivitei, no. 365, district 1, Romania Telephone / Fax number: 0374 180 470 Unique Registration Code at the National Office of Trade Registry: 8422035 Order number on the Trade Registry: J1996003709402 EUID:ROONRC.J1996003709402 Subscribed and paid-in share capital: 132,870,492 RON Total number of shares: 531,481,968 531,481,968 (out of which 427,042 own shares, without voting rights and 531,054,926 shares with voting rights) Regulated market on which the issued securities are traded: Bucharest Stock Exchange, Premium Category

Availability of the 2024 Preliminary results Conference Call presentation

MED LIFE S.A. informs shareholders and investors about the availability, on the Company's website, in the Investor Relations section / Reports and Presentations / Financial Reports (https://www.medlife.ro/investor-relations/reports-and-presentations/financial-reports) and on the Bucharest Stock Exchange's website (symbol M) of the Presentation related to the 2024 Preliminary results Conference Call with analysts and investors.

Mihail Marcu Chief Executive Officer

______________